Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis

Applied and Environmental Microbiology

Volumn 77, Issue 23, 2011, Pages 8272-8279

  Meng, Xiangpeng ^a   Shi, Yibo ^a   Ji, Wenhui ^a   Meng, Xueling ^b   Zhang, Jing ^a   Wang, Hengan ^a   Lu, Chengping ^b   Sun, Jianhe ^a   Yan, Yaxian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANIMAL PATHOGENS; ANTI-BIOFILM; BACTERIAL BIOFILM; BIOFILM STRUCTURE; CIPROFLOXACIN; DOSE-DEPENDENT; EXOPOLYSACCHARIDES; KANAMYCINS; RELEASED CELLS;

ANTIBIOTICS; BACTERIOPHAGES; CELL CULTURE; SCANNING ELECTRON MICROSCOPY;

BIOFILMS;

ANTIINFECTIVE AGENT; LYSIN; MUCOPROTEIN; VIRUS PROTEIN;

ANTIBIOTICS; ANTIBODY; BACTERIOPHAGE; BACTERIUM; BIOCONTROL AGENT; BIOFILM; BIOLOGICAL CONTROL; BIOTECHNOLOGY; DISEASE TREATMENT; DISPERSAL; PATHOGEN; PIG; POLYMER;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; DRUG EFFECT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS PHAGE; STREPTOCOCCUS SUIS; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; MICROSCOPY, ELECTRON, SCANNING; MUCOPROTEINS; STREPTOCOCCUS PHAGES; STREPTOCOCCUS SUIS; VIRAL PROTEINS;

EID: 83255192312     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05151-11     Document Type: Article

References (35)

1. Arends, J. P., and H. C. Zanen. 1988. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10:131-137.
2. Briandet, R., P. Lacroix, and M. Renault. 2008. Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms. Appl. Environ. Microbiol. 74:2135-2143.
3. Corbin, B. D., R. J. McLean, and G. M. Aron. 2001. Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm. Can. J. Microbiol. 47:680-684.
4. Curtin, J. J., and R. M. Donlan. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50:1268-1275.
5. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
6. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1995. Lytic infections of Escherichia coli biofilms by bacteriophage T4. Can. J. Microbiol. 41:12-18.
7. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1996. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J. Ind. Microbiol. 16:331-341.
8. Dubois, M., K. Gilles, J. K. Hamilton, P. A. Rebers, and F. A. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Chem. 28:350-356.
9. Foongladda, S., D. Roengsanthia, and W. Arjrattanakool. 2002. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 6:1118.
10. Gilbert, P., J. Das, and I. Folez. 1997. Biofilm susceptibility to antimicrobials. Adv. Dent. Res. 11:160-167.
11. Gottschalk, M., and M. Segura. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76: 259-272.
12. Grenier, D., L. Grignon, and M. Gottschalk. 2009. Characterisation of biofilm formation by a Streptococcus suis meningitis isolate. Vet. J. 179:292-295.
13. Hanlon, G. W., S. P. Denyer, C. J. Olliff, and L. J. Ibrahim. 2001. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 67: 2746-2753.
14. Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents. 30:118-128.
15. Hughes, K. A., I. W. Sutherland, and M. V. Jones. 1998. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144:3039-3047.
16. Hughes, K. A., I. W. Sutherland, and M. V. Jones. 1998. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. J. Appl. Microbiol. 85:583-598.
17. Jado, I., et al. 2003. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J. Antimicrob. Chemother. 52:967-973.
18. Jin, H., et. al. 2006. Biofilm formation by field isolates and reference strains of Haemophilus parasuis. Vet. Microbiol. 118:117-123.
19. Knezevic, P., and O. Petrovic. 2008. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm. J. Microbiol. Methods 74:114-118.
20. Landini, P. 2009. Cross-talk mechanisms in biofilm formation and responses to environmental and physiological stress in Escherichia coli. Res. Microbiol. 160:259-266.
21. Loeffler, J. M., D. Nelson, and V. A. Fischetti. 2001. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294: 2170-2172.
22. Lu, T. K., and J. J. Collins. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. U. S. A. 104:11197-11202.
23. Ma, Y., and C. Lu. 2008. Isolation and identification of a bacteriophage capable of infecting Streptococcus suis type 2 strains. Vet. Microbiol. 132: 340-347.
24. Marrie, T. J., and J. W. Costerton. 1984. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J. Clin. Microbiol. 19:687-693.
25. Merril, C. R., D. Scholl, and S. L. Adhya. 2003. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2:489-497.
26. Ngwai, Y. B., Y. Adachi, Y. Ogawa, and H. Hara. 2006. Characterization of biofilm-forming abilities of antibiotic-resistant Salmonella typhimurium DT104 on hydrophobic abiotic surfaces. J. Microbiol. Immunol. Infect. 39: 278-291.
27. Rashel, M., et al. 2007. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φ{symbol}11MR J. Infect. Dis. 196:1237-1247.
28. Read, R. R., and J. W. Costerton. 1987. Purification and characterization of adhesive exopolysaccharides from Pseudomonas putida and Pseudomonas fluorescens. Can. J. Microbiol. 33:1080-1090.
29. Sass, P., and G. Bierbaum. 2007. Lytic activity of recombinant bacteriophage φ11 and φ12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl. Environ. Microbiol. 73:347-352.
30. Schuch, R., D. Nelson, and V. A. Fischetti. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418:884-889.
31. Sharma, S. D., J. Mullenax, F. G. Araujo, H. A. Erlich, and J. S. Remington. 1983. Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J. Immunol. 131:977-983.
32. Stoodley, P., K. Sauer, D. G. Davies, and J. W. Costerton. 2002. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56:187-209.
33. Sutherland, I. W., K. A. Hughes, L. C. Skillman, and K. Tait. 2004. The interaction of phage and biofilm. FEMS Microbiol. Lett. 232:1-6.
34. Trottier, S., R. Higgins, G. Brochu, and M. Gottschalk. 1991. A case of human endocarditis due to Streptococcus suis in North America. Rev. Infect. Dis. 13:1251-1252.
35. Wang, Y., J. H. Sun, and C. P. Lu. 2009. Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci. Curr. Microbiol. 58:609-615.